xomolix 2,5 mg/ml injektionslösung
kyowa kirin holdings b.v. - droperidol - injektionslösung - droperidol 2.5mg
tostran 2% gel
kyowa kirin holdings b.v. (8182242) - testosteron - gel - teil 1 - gel; testosteron (00319) 20 milligramm
rectogesic 4 mg/g rektalsalbe
kyowa kirin holdings b.v. (8182242) - glyceroltrinitrat-lösung (ph.eur.) - rektalsalbe - glyceroltrinitrat-lösung (ph.eur.) (00825) 4 milligramm
xomolix 2,5 mg/ml injektionslösung
kyowa kirin limited (bs 1) - droperidol - injektionslösung - droperidol 2.5mg
tostran 2% - gel
kyowa kirin international - testosteron - 3-oxoandrosten (4) deriva
crysvita
kyowa kirin holdings b.v. - burosumab - hypophosphatemia, familial; hypophosphatemic rickets, x-linked dominant; osteomalacia - medikamente zur behandlung von knochenerkrankungen - crysvita is indicated for the treatment of x-linked hypophosphataemia, in children and adolescents aged 1 to 17 years with radiographic evidence of bone disease, and in adults. crysvita is indicated for the treatment of fgf23-related hypophosphataemia in tumour-induced osteomalacia associated with phosphaturic mesenchymal tumours that cannot be curatively resected or localised in children and adolescents aged 1 to 17 years and in adults.
abstral 800 mikrogramm sublingualtabletten
kyowa kirin holdings b.v. (8182242) - fentanylcitrat - sublingualtablette - teil 1 - sublingualtablette; fentanylcitrat (06904) 1257 mikrogramm
abstral 600 mikrogramm sublingualtabletten
kyowa kirin holdings b.v. (8182242) - fentanylcitrat - sublingualtablette - teil 1 - sublingualtablette; fentanylcitrat (06904) 942,6 mikrogramm
abstral 400 mikrogramm sublingualtabletten
kyowa kirin holdings b.v. (8182242) - fentanylcitrat - sublingualtablette - teil 1 - sublingualtablette; fentanylcitrat (06904) 628,4 mikrogramm
abstral 300 mikrogramm sublingualtabletten
kyowa kirin holdings b.v. (8182242) - fentanylcitrat - sublingualtablette - teil 1 - sublingualtablette; fentanylcitrat (06904) 471,3 mikrogramm